Hoth Therapeutics Stock Investor Sentiment

HOTH Stock  USD 1.26  0.02  1.56%   
Under 50% of Hoth Therapeutics' traders are presently thinking to get in. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that some investors are interested at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  

Hoth Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at news.google.com         
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Application...
Yahoo News
over two weeks ago at finance.yahoo.com         
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025
Yahoo News
over two weeks ago at thelincolnianonline.com         
Hoth Therapeutics, Inc. Short Interest Up 117.4 percent in December
news
over two weeks ago at www.macroaxis.com         
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Biotech Stock Roundup NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data More
Yahoo News
over three weeks ago at finance.yahoo.com         
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries
Yahoo News
over three weeks ago at finance.yahoo.com         
Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial HT-001 Delivers 100 percent Success in Com...
Yahoo News
over three weeks ago at benzinga.com         
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday?
benzinga news
over three weeks ago at gurufocus.com         
Hoth Therapeutics Soars 215 percent on Breakthrough Cancer Treatment Success
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Hoth Therapeutics Soars 215 percent on Breakthrough Cancer Treatment Success
Yahoo News
over a month ago at finance.yahoo.com         
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Trea...
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
Hoth Up on Bitcoin Buy - Baystreet.ca
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Hoth Therapeutics that are available to investors today. That information is available publicly through Hoth media outlets and privately through word of mouth or via Hoth internal channels. However, regardless of the origin, that massive amount of Hoth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hoth Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hoth Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hoth Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hoth Therapeutics alpha.

Hoth Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Hoth Therapeutics faces Nasdaq delisting over stock price - Investing.com
11/01/2024
2
Hoth Therapeutics Posts Quarterly Earnings Results, Misses Expectations By 0.01 EPS
11/15/2024
3
Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3
11/27/2024
4
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
12/20/2024
5
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday
01/07/2025
6
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries
01/08/2025
7
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
01/14/2025
8
Hoth Therapeutics, Inc. Short Interest Up 117.4 percent in December
01/16/2025
9
Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
01/24/2025

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device